Wu, Shengjun
Lin, Xuexiang
Hui, Kwok Min
Yang, Su
Wu, Xuanlan
Tan, Yichen
Li, Meimei
Qin, Ai-Qing
Wang, Qingxi
Zhao, Qi
Ding, Pengfei
Shi, Kaisheng
Li, X. James http://orcid.org/0000-0002-0112-3526
Funding for this research was provided by:
Foundation for the National Institutes of Health (AI077117, AI082728)
Chinese Medicine Research Program of Zhejiang Province (2018244788)
Article History
Received: 28 August 2019
Accepted: 7 December 2019
First Online: 27 December 2019
Competing interests
: Research support by Cellex (Shenzhen) was provided to Shandong University Jinan Central Hospital and Yantai Yuhuangding Hospital to conduct the study. The study was designed collectively by the hospitals and Cellex (Shenzhen) according to institutional and CFDA requirements. During the study, these sites were inspected by CFDA affiliated Provincial Food and Drug Administrations of Shandong and Jiangsu provinces. No funding was provided to Zhejiang University Sir Run Run Shaw Hospital.<b> Equity ownership:</b> The following authors own equity shares of Cellex (Shenzhen): X.L., Y.T., A.Q.Q., K.S. and X.J.L. K.M.H. and X.J.L. have equity ownership in Cellex, Incorporated.